TLR3 and myeloid sarcoma: Indeed, we have previously demonstrated that the TLR3-IFN-β pathway is desensitized in MS patient PBMCs, suggesting that MS patients may be pre-sensitized to viral infection showing some form of TLR3 tolerance.